| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUQ pavillon CHUL and Laval University, Québec, Canada
b Departments of Medicine, SPI/DRM, CE-Saclay 91191 Gif/Yvette CEDEX, France
c Departments of Physiology, Faculty of Medicine, SPI/DRM, CE-Saclay 91191 Gif/Yvette CEDEX, France
d CEA, SPI/DRM, CE-Saclay 91191 Gif/Yvette CEDEX, France
e Inserm U-348, Hôpital Lariboisière, 7547 Paris CEDEX 10, France
f Department of Microbiology and Immunology, University of Adelaide, Adelaide, South Australia, Australia
Proinflammatory agents were assessed for their capacity to stimulate the expression of the inducible cyclooxygenase isoform (COX-2) in human neutrophils. A number of agents, including PMA, opsonized bacteria and zymosan, LPS, GM-CSF, TNF-
, and fMLP, induced COX-2 protein expression through signaling pathways involving transcription and protein synthesis events. Northern blots showed that freshly isolated neutrophils expressed low levels of COX-2 mRNA, which rapidly increased after incubation with inflammatory agents. A characterization of the signal transduction pathways leading to COX-2 protein expression was initiated. In LPS-treated neutrophils, efficient induction of COX-2 required the presence of serum and involved ligand binding to the CD14 surface antigen. The specific inhibitor of p38 mitogen-activated protein kinase (p38 MAPK), SB 203580, had little effect on the induction of COX-2 expression in neutrophils, in contrast to what had been previously observed with other inflammatory cell types. Depending on the agonist present, ethanol differentially blocked the stimulated expression of COX-2, raising the possibility that phospholipase D activation might take part in the process of COX-2 induction. Major COX-2-derived prostanoids synthesized by inflammatory neutrophils were identified by liquid-chromatography and tandem mass-spectrometry as TXA2 and PGE2. The agonist-induced synthesis of TXA2 and PGE2 was effectively blocked by cycloheximide and by the specific COX-2 inhibitor NS-398. These results show that COX-2 can be induced in an active state by different classes of inflammatory mediators in the neutrophil. They support the concept that, in these cells, the COX-2 isoform is preeminent over COX-1 for the stimulated-production of prostanoids, and also suggest that neutrophil COX-2 displays a distinct profile of expression among circulatory cells.—Pouliot, M., Gilbert, C., Borgeat, P., Poubelle, P. E., Bourgoin, S., Créminon, C., Maclouf, J., McColl, S. R., Naccache, P. H. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J. 612, 1109–1123 (1998)
Key Words: thromboxane • dexamethasone • lipopolysaccharide • cyclooxygenase
This article has been cited by other articles:
|
|
 |
|
  M. Joo, M. Kwon, R. T. Sadikot, P. J. Kingsley, L. J. Marnett, T. S. Blackwell, R. S. Peebles Jr, Y. Urade, and J. W. Christman Induction and Function of Lipocalin Prostaglandin D Synthase in Host Immunity J. Immunol., August 15, 2007; 179(4): 2565 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hattermann, S. Picard, M. Borgeat, P. Leclerc, M. Pouliot, and P. Borgeat The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis FASEB J, May 1, 2007; 21(7): 1575 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vega, P. Chacon, G. Alba, R. El Bekay, J. Monteseirin, J. Martin-Nieto, and F. Sobrino Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils J. Leukoc. Biol., July 1, 2006; 80(1): 152 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Rouzer and L. J. Marnett Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus J. Biol. Chem., July 22, 2005; 280(29): 26690 - 26700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fukunaga, P. Kohli, C. Bonnans, L. E. Fredenburgh, and B. D. Levy Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury J. Immunol., April 15, 2005; 174(8): 5033 - 5039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Cadieux, P. Leclerc, M. St-Onge, A.-A. Dussault, C. Laflamme, S. Picard, C. Ledent, P. Borgeat, and M. Pouliot Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal J. Cell Sci., April 1, 2005; 118(7): 1437 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cipollone, B. Rocca, and C. Patrono Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. A. Singer, K. J. Baker, A. McCaffrey, D. P. AuCoin, M. A. Dechert, and W. T. Gerthoffer p38 MAPK and NF-{kappa}B mediate COX-2 expression in human airway myocytes Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1087 - L1098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gilbert, S. Levasseur, P. Desaulniers, A.-A. Dusseault, N. Thibault, S. G. Bourgoin, and P. H. Naccache Chemotactic Factor-Induced Recruitment and Activation of Tec Family Kinases in Human Neutrophils. II. Effects of LFM-A13, a Specific Btk Inhibitor J. Immunol., May 15, 2003; 170(10): 5235 - 5243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pouliot, M.-E. Fiset, M. Masse, P. H. Naccache, and P. Borgeat Adenosine Up-Regulates Cyclooxygenase-2 in Human Granulocytes: Impact on the Balance of Eicosanoid Generation J. Immunol., November 1, 2002; 169(9): 5279 - 5286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. OGUMA, K. ASANO, T. SHIOMI, K. FUKUNAGA, Y. SUZUKI, M. NAKAMURA, H. MATSUBARA, H. K. SHELDON, K. J. HALEY, C. M. LILLY, et al. Cyclooxygenase-2 Expression during Allergic Inflammation in Guinea-Pig Lungs Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 382 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Schuster, J. K. Kozlowski, T. McCarthy, J. Morrow, and A. Stephenson Effect of endotoxin on oleic acid lung injury does not depend on priming J Appl Physiol, November 1, 2001; 91(5): 2047 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. THURNHER, C. ZELLE-RIESER, R. RAMONER, G. BARTSCH, and L. HOLTL The disabled dendritic cell FASEB J, April 1, 2001; 15(6): 1054 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gilbert, F. Barabe, E. Rollet-Labelle, S. G. Bourgoin, S. R. McColl, B. B. Damaj, and P. H. Naccache Evidence for a Role for SAM68 in the Responses of Human Neutrophils to Ligation of CD32 and to Monosodium Urate Crystals J. Immunol., April 1, 2001; 166(7): 4664 - 4671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Serhan, I. M. Fierro, N. Chiang, and M. Pouliot Cutting Edge: Nociceptin Stimulates Neutrophil Chemotaxis and Recruitment: Inhibition by Aspirin-Triggered-15-Epi-Lipoxin A4 J. Immunol., March 15, 2001; 166(6): 3650 - 3654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. WOLLIN, S. UHLIG, R. NÜSING, and A. WENDEL Granulocyte-Macrophage Colony-Stimulating Factor Amplifies Lipopolysaccharide-induced Bronchoconstriction by a Neutrophil- and Cyclooxygenase 2-Dependent Mechanism Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 443 - 450. [Abstract] [Full Text]
|
|
|
|
|
|
C. Kerkhoff, M. Klempt, V. Kaever, and C. Sorg The Two Calcium-binding Proteins, S100A8 and S100A9, Are Involved in the Metabolism of Arachidonic acid in Human Neutrophils J. Biol. Chem., November 12, 1999; 274(46): 32672 - 32679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Surette, N. Dallaire, N. Jean, S. Picard, and P. Borgeat Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils FASEB J, November 1, 1998; 12(14): 1521 - 1531. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
